Skip to main content
Article thumbnail
Location of Repository

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment

By Bruno Spire, Patrizia Carrieri, Pal Sopha, Camelia Protopopescu, Narom Prak, Catherine Quillet, Chanchhaya Ngeth, Laurent Ferradini, Jean-François Delfraissy and Didier Laureillard


BACKGROUND: The long-term maintenance of antiretroviral therapy (ART) remains an important issue, especially in limited-resource settings where additional barriers exist. A cross-sectional study was performed 24 months after ART initiation for patients treated in Cambodia in order to estimate the prevalence and identify determinants of non-adherence. METHODS: Adults receiving ART for 24 +/- 2 months were considered eligible for the study. Self-reported non-adherence was defined according to an algorithm based on six items. The questionnaire also assessed ART-related side effects and HIV disclosure. HIV-1 RNA plasma viral load was measured using real-time PCR. Multivariate rare events logistic regression analysis was used to identify independent factors associated with non-adherence. RESULTS: A total of 346 patients participated in the study. At 24 months, 95% of patients were adherent, 80% had HIV RNA <40 copies/ml and 75% had CD4+ T-cell counts >200 cells/mm3. Virological success was significantly higher in adherent patients than in non-adherent patients (81% versus 56%, P=0.021). Living in a rural area, limited HIV disclosure and perceived lipodystrophy were independently associated with non-adherence. CONCLUSIONS: At 24 months, adherence to ART was high and explained positive virological outcomes. In order to maintain adherence and long-term virological benefits, special attention should be given to patients living in rural areas, those with lipodystrophy-related symptoms and others who express difficulties disclosing their condition to close family members

Year: 2008
OAI identifier:
Provided by: MSF Field Research

Suggested articles


  1. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.
  2. (2006). Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med
  3. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002,54:1481-1496. in se rm -0 1, v er sio n - 1
  4. Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences.
  5. Development and validation of a self-completed HIV symptom index.
  6. (2000). Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self- reports and serum protease inhibitor concentrations in the French Manif
  7. Efficacy of an Educational and Counseling Intervention on Adherence to Highly Active Antiretroviral Therapy: French Prospective Controlled Study.
  8. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.
  9. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials.
  10. Estimating Risk and Rate Levels, Ratios, and Differences in Case-Control Studies.
  11. Factors Associated With Nonadherence to Highly Active Antiretroviral Therapy: A 5-Year Follow-Up Analysis With Correction for the Bias Induced by Missing Data in the Treatment Maintenance Phase.
  12. Failure to Maintain Adherence to HAART in a Cohort of French HIV-Positive Injecting Drug Users.
  13. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy.
  14. Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa.
  15. Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study.
  16. Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up.
  17. (2007). Lipodystrophy syndrome associated with antiretroviral therapy in HIV patients: considerations for psychosocial aspects. Rev Lat Am Enfermagem
  18. Logistic Regression in Rare Events Data. Political analysis
  19. Making the Most of Statistical Analyses.
  20. (2003). Management of HIV-related stigma and adherence to HAART: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA
  21. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa.
  22. Nonadherence among HIV-infected injecting drug users: the impact of social instability.
  23. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
  24. (2000). Psychological variables and adherence to antiretroviral treatment. An Med Interna
  25. Rare Events Logistic Regressio.
  26. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.
  27. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments.
  28. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis.
  29. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.
  30. Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection.
  31. Social stigma concerns and HIV medication adherence.
  32. The care of HIV-infected adults in rural areas of the United States.
  33. The detection of nonadherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.
  34. The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort.
  35. The relationship of disease severity, health beliefs and medication adherence among HIV patients.
  36. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.
  37. Therapeutic care centered on compliance.
  38. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.
  39. (1999). Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.